Colosseum Dental Group appoints Dr Farzeela Rupani as new CMO
Dr Farzeela Rupani has been appointed as Group Chief Medical Officer (CMO) of Colosseum Dental Group. She will start her new role on 1 September 2023, in addition to her current role as Chief Medical Officer of Colosseum Dental UK.
Since joining in 2021, Farzeela made an immediate positive impact on practitioners in the UK and has been instrumental in strengthening the proposition for dentists, leading to an improved retention, at Colosseum Dental UK. Farzeela will act as Chairperson of the Medical Board, which oversees the clinical standards and governance within the Colosseum Dental Group and is composed of various country CMOs, and advise the Board of Directors and Executive Committee on all medical matters. In her role as Group CMO, Farzeela further assumes responsibility for the Group’s Learning & Development Program (including our Academy) and be part of the new Group HR organisation to gain efficiencies between the medical and HR function.
Farzeela will succeed Dr Eddie Coyle, who will pursue other opportunities after five years of service. Eddie has built and significantly improved our medical governance and the sharing of best practices across markets during his time with Colosseum. He has been instrumental in setting up our medical function, in particular the Medical Board, the Colosseum Academy as well as establishing our first examination procedures, engaging our medical organisation and ensuring a medical focus throughout CDG. Eddie further led the organisation through the recent pandemic from a medical side.
We thank Eddie for his dedication and commitment over the past five years and wish him all the best for the future.
Changes in The Benelux organisation
Jarkko Jokinen assumes the CEO position of The Netherlands & Belgium, in addition to his responsibilities in Finland, effective 1 September 2023. Under Jarkko’s leadership over the last four years, Oral has been transformed into the most admired Finish dental care provider, amongst dental professionals and patients alike. His experience will be instrumental for the sustainable success of our Dutch business going forward.
To complement the leadership, Teemu Arima will act as CFO The Netherlands & Belgium, also effective 1 September 2023. In his previous role as CFO of Colosseum Dental UK, he made a significant contribution to the turnaround of the UK operations. Teemu started his career as Financial Controller of Oral in 2016 and thereafter served as Group Financial Controller until he joined the UK in 2021.
Jarkko and Teemu will succeed Patrick Bakker (CEO The Netherlands & Belgium) and Maarten ter Haar (CFO The Netherlands & Belgium) who will leave Colosseum Dental after a handover period.
We would like to thank Patrick and Maarten for their contribution and efforts to integrate The Netherlands & Belgium, our biggest acquisition to date, into the Colosseum family during the past two years and wish them the best of success in their future endeavours.